News

Lexicon Pharmaceuticals Showcases Pilavapadin at Major Events

Lexicon Pharmaceuticals Showcases Pilavapadin at Major Events

Lexicon Pharmaceuticals Highlights Pilavapadin's Potential

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is poised to make significant strides in the pain management field with its investigational drug, pilavapadin. The company has announced presentations of clinical data surrounding pilavapadin at three noteworthy medical meetings. This treatment focuses on diabetic peripheral neuropathic pain (DPNP) and showcases Lexicon's dedication to improving patient outcomes.

Upcoming Presentations on Pilavapadin

These presentations are set for high-profile gatherings where experts will discuss the broad spectrum of pilavapadin's clinical data. This innovative treatment stands out because of its unique mechanism, targeting AAK1, which is vital for pain signaling without engaging the opioid pathways commonly associated with pain management.

1. NeuroDiab Conference

The NeuroDiab conference is happening from September 11-14 in Bucharest. On September 13, Lexicon will feature a lecture titled "New Promise for Painful Diabetic Neuropathy". This presentation will dive into the results from recent clinical trials that investigate pilavapadin's effects on diabetic neuropathic pain, presented by Rodica Pop-Busui M.D., Ph.D., a respected figure in diabetes care and research.

2. European Association for the Study of Diabetes (EASD)

Next, the EASD meeting on September 16-19 in Vienna will serve as another platform for Lexicon. On September 17, there will be an oral presentation sharing insights from a Phase 2b, randomized, placebo-controlled study. This significant research elaborates on pilavapadin's results from a dose-ranging trial illustrating its efficacy and safety.

3. Arrowhead's Annual Pain Therapeutics Summit

In October, Lexicon will present at the Arrowhead's 19th Annual Pain Therapeutics Summit, which occurs on the 13th and 14th in San Diego. Suma Gopinathan, Ph.D., will lead a poster discussion focused on the findings from the Phase 2b PROGRESS trial. These sessions are critical as they further position pilavapadin as a prominent solution for patients suffering from neuropathic pain.

Exploring Pilavapadin's Mechanism

Pilavapadin is an investigational small molecule that offers new hope for patients with painful diabetic neuropathy. Lexicon scientists have utilized their gene science technologies to design this compound specifically to inhibit AAK1. This inhibition disrupts the reuptake of neurotransmitters involved in pain signaling, presenting a promising non-opioid alternative for pain management. By protecting against the typical side effects associated with opioids, pilavapadin has shown considerable potential during testing.

Lexicon Pharmaceuticals: Pioneering Medicines for Patients

Lexicon’s mission goes beyond just developing pilavapadin. The company aims to transform lives through innovative medicines, particularly within intricate therapeutic areas. Their Genome5000™ program has facilitated the identification of significant protein targets in various conditions, thereby supporting the design of focused treatments. Moreover, Lexicon is actively pursuing drug candidates to tackle various indications including hypertrophic cardiomyopathy and obesity.

Frequently Asked Questions

What is pilavapadin?

Pilavapadin is an investigational oral drug being developed by Lexicon Pharmaceuticals for the treatment of diabetic peripheral neuropathic pain.

When are the presentations for pilavapadin scheduled?

The presentations will be held at NeuroDiab in September, EASD in September, and Arrowhead's Summit in October.

Who is presenting the data at the conferences?

The primary presenters include Rodica Pop-Busui, M.D., Ph.D., and Suma Gopinathan, Ph.D.

How does pilavapadin work?

Pilavapadin inhibits AAK1, which decreases the reuptake of neurotransmitters involved in pain without affecting opiate pathways.

What is Lexicon Pharmaceuticals' overall goal?

Lexicon aims to pioneer innovative medicines that transform patient lives through targeted therapies for various diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 89

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 168

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 113

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 99

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 183

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 149

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 150

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 136

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Insight Into Midland TX Real Estate Sales Timing

Updated Category News Views 46

How Fast Do Homes Move in Midland? This ain't my first rodeo predicting the real estate rollercoaster in Texas. Midland's housing market is one nifty beast—homes can either sell like hotcakes or just sit gathering dust. You got HelloNation pulling in DeLaura Gammage, a pro who knows the terrain like the back of her hand, to spell out the why and how long it'll take to...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 122

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading

Top 5 Most Recently Viewed Articles

Chuyuan Group's Transformative Journey Towards Sustainable Success

Updated Category News Views 226

Chuyuan Group's Path to Sustainability and Growth In recent years, Chuyuan Group has significantly transformed its operations, embracing high-quality development in response to the evolving regulatory landscape. As the industry landscape changes, companies like Chuyuan must adapt to remain competitive and environmentally responsible. Understanding the Shift: Old Yang and...

Continue Reading
Adani Bonds Face Downgrade Risk Amid U.S. Bribery Scandal

Updated Category News Views 355

Fitch Ratings Puts Adani Group Bonds on Negative Watch In a significant move, Fitch Ratings has placed bonds from various units of the Adani Group on a watchlist for potential downgrades. This action follows serious allegations against the conglomerate's top executives, who are facing U.S. charges related to bribery and fraud. Implications of the Watch Status Fitch's...

Continue Reading
Investigation of Arbor Realty Trust: What Investors Should Know

Updated Category News Views 81

Understanding the Investigation of Arbor Realty Trust Faruqi & Faruqi, LLP, a well-known national securities law firm, is currently looking into claims related to Arbor Realty Trust, Inc. (NYSE: ABR). Investors who have suffered losses exceeding $100,000 while investing in Arbor are encouraged to get in touch for more information and support. Who Should Reach Out to...

Continue Reading
Qualcomm's Strategic Move: Potential Intel Acquisition Talks

Updated Category News Views 185

Qualcomm's Interest in Intel's Assets Recently, Qualcomm has made headlines by showing interest in buying parts of Intel. This move seems to be a strategic effort by Qualcomm to strengthen its presence in the competitive technology market, especially within the chip manufacturing sector. Shifting Market Dynamics Intel, a leader in chip production, is currently facing...

Continue Reading
Refined Energy Corp Expands Partnership with Eagle Plains Resources

Updated Category News Views 113

Refined Energy Corp Strengthens Its Partnership Refined Energy Corp announces an important amendment to its agreement with Eagle Plains Resources Ltd. The key focus of this amendment is to enhance their collaboration on the Dufferin Project, a project located in Canada's Athabasca Basin, known for its rich mineral deposits. Details of the Amended Agreement In a recent...

Continue Reading